Lantheus Holdings (LNTH) Share-based Compensation (2014 - 2026)
Lantheus Holdings (LNTH) reported Share-based Compensation of $16.0 million for Q1 2026, down 24.33% year-over-year from $21.2 million in Q1 2025, and down 8.56% quarter-over-quarter from $17.5 million in Q4 2025.
Lantheus Holdings (LNTH) Share-based Compensation (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Share-based Compensation data on file, last reported at $16.0 million in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $16.0 million, down 24.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $80.4 million (down 2.19% YoY), and the FY2025 annual result was $85.6 million, up 12.0% from the prior year.
- Share-based Compensation fell to $16.0 million in Q1 2026 per LNTH's latest filing, from $17.5 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $24.5 million in Q3 2025 and troughed at $5.6 million in Q1 2022.
- A 5-year average of $15.2 million and a median of $15.4 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation jumped 109.54% in 2022, then slipped 24.33% in 2026.
- A 5-year view of Share-based Compensation shows it stood at $8.1 million in 2022, then jumped by 74.45% to $14.2 million in 2023, then jumped by 56.39% to $22.2 million in 2024, then retreated by 20.85% to $17.5 million in 2025, then retreated by 8.56% to $16.0 million in 2026.
- Business Quant data shows LNTH's Share-based Compensation at $16.0 million in Q1 2026, $17.5 million in Q4 2025, and $24.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.04 Mn |
| Mar 31, 2026 | 16.04 Mn |
| Dec 31, 2025 | 17.54 Mn |
| Dec 31, 2025 | 17.54 Mn |
| Sep 30, 2025 | 24.50 Mn |
| Sep 30, 2025 | 24.50 Mn |
| Jun 30, 2025 | 22.32 Mn |
| Jun 30, 2025 | 22.32 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Dec 31, 2024 | 22.16 Mn |
| Dec 31, 2024 | 22.16 Mn |
| Sep 30, 2024 | 20.37 Mn |
| Sep 30, 2024 | 20.37 Mn |
| Jun 30, 2024 | 18.48 Mn |
| Jun 30, 2024 | 18.48 Mn |
| Mar 31, 2024 | 15.38 Mn |
| Mar 31, 2024 | 15.38 Mn |
| Dec 31, 2023 | 14.17 Mn |
| Dec 31, 2023 | 14.17 Mn |